CRYOPORT, INC. Convertible Debt, Noncurrent
CRYOPORT, INC. (CYRX) had Convertible Debt, Noncurrent of $184.80 million as of 2025-09-30, per its 10-Q filed 2025-11-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt and Lease Obligation › Long-Term Debt, Excluding Current Maturities
us-gaap:ConvertibleDebtNoncurrent · last filed 2026-03-05
- 2025-09-30: Convertible Debt, Noncurrent $184.80M.
- 2025-06-30: Convertible Debt, Noncurrent $184.50M.
- 2025-03-31: Convertible Debt, Noncurrent $184.21M.
- 2024-12-31: Convertible Debt, Noncurrent $183.92M.
| Period end | Convertible Debt, Noncurrent |
|---|---|
| 2025-09-30 | $184.80M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $184.50M 10-Q · filed 2025-08-12 |
| 2025-03-31 | $184.21M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $183.92M 10-K · filed 2026-03-05 |
| 2024-09-30 | $183.63M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $355.67M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $379.15M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $378.55M 10-K · filed 2025-03-07 |
| 2023-09-30 | $377.95M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $407.99M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $407.35M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $406.71M 10-K · filed 2024-03-13 |
| 2022-09-30 | $406.07M 10-Q · filed 2022-11-04 |
| 2022-06-30 | $405.44M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $404.80M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $404.17M 10-K · filed 2023-02-28 |
| 2021-09-30 | $111.92M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $111.73M 10-Q · filed 2021-08-06 |
| 2021-03-31 | $111.54M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $111.34M 10-K · filed 2022-02-28 |
| 2020-09-30 | $111.16M 10-Q · filed 2020-11-06 |
| 2020-06-30 | $110.98M 10-Q · filed 2020-08-10 |
| 2019-12-31 | $0.00 10-K · filed 2021-03-01 |
| 2019-09-30 | $14.74M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $14.72M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $14.71M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $14.71M 10-K · filed 2020-03-10 |
| 2017-12-31 | $0.00 10-K · filed 2019-03-13 |
| 2012-03-31 | $0.00 10-K · filed 2012-06-27 |
| 2011-12-31 | $0.00 10-Q · filed 2012-02-21 |
| 2011-09-30 | $0.00 10-Q · filed 2011-11-14 |
| 2011-06-30 | $0.00 10-Q · filed 2011-08-15 |
| 2011-03-31 | $421.73K 10-K · filed 2012-06-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |